newsfilter
← Latest News
Business Wire·

Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

Revenue of $194.4 million, compared to $163.8 million in second quarter 2024 Modified 2025 revenue guidance of $850 – $900 million Net income of $35.1 million, compared to $35.5 million in second quarter